Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Daiichi Sankyo (United States)

InstitutionResearch output, impact & collaborations

Daiichi Sankyo (United States) is a research organisation in Parsippany, US. OpenAlex records 2,423 works and 261,680 citations for it. 824 researchers list it as their most recent affiliation.

2,423
Works
261,680
Citations
824
Researchers
53
Avg h-index

How has Daiichi Sankyo (United States)'s publication output changed over time?

ScholarIQpublication output · 2016–2018

Output grew100% over the shown period — from 1 works in 2016 to 2 in 2018.

1
2
20162018

What are the most-cited papers on Daiichi Sankyo (United States)?

ScholarIQmost cited works
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer
The Lancet. 20163,735 Citations
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott, Mahrukh Huseni, Michael B. Atkins, Robert J. Motzer, Brian I. Rini, Bernard Escudier, Lawrence Fong, Richard W. Joseph, Sumanta K. Pal, James A. Reeves, Mario Sznol, John D. Hainsworth, W. Kimryn Rathmell, Walter M. Stadler, Thomas E. Hutson, Martin Gore, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Riccardo Danielli, Viktor Gruenwald, Toni K. Choueiri, Dorothee Nickles, Suchit Jhunjhunwala, Elisabeth Piault‐Louis, Alpa Thobhani, Jiaheng Qiu, Daniel S. Chen, Priti S. Hegde, Christina Schiff, Gregg Fine, Thomas Powles
Nature Medicine. 20181,263 CitationsOPEN ACCESS
High response rate to PD-1 blockade in desmoplastic melanomas
Zeynep Eroglu, Jesse M. Zaretsky, Siwen Hu‐Lieskovan, Dae Won Kim, Alain P. Algazi, Douglas B. Johnson, Elizabeth Liniker, Benjamin Y. Kong, Rodrigo Ramella Munhoz, Suthee Rapisuwon, Pier Federico Gherardini, Bartosz Chmielowski, Xiaoyan Wang, I. Peter Shintaku, Cody Wei, Jeffrey A. Sosman, Richard W. Joseph, Michael A. Postow, Matteo S. Carlino, Wen-Jen Hwu, Richard A. Scolyer, Jane L. Messina, Alistair J. Cochran, Georgina V. Long, Antoni Ribas
Nature. 2018333 CitationsOPEN ACCESS

How much of the research on Daiichi Sankyo (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
67%
Hybrid
0%
Bronze
0%
Closed
33%

Related on ScholarIQ

HER2/EGFR in Cancer Research
Top Topic
Atrial Fibrillation Management and Outcomes
Top Topic
Lung Cancer Treatments and Mutations
Top Topic
Advanced Breast Cancer Therapies
Top Topic
Antiplatelet Therapy and Cardiovascular Diseases
Top Topic
Lung Cancer Research Studies
Top Topic
470M+ articles · free account